Search research articles
Contact Us
Filters
Showing results (61-70 of 120) with videos related to
Page
of 12
Sort By:
Cancer
|
September 15, 1988
5-Fluorouracil and isoprinosine in the treatment of advanced colorectal cancer. A limited phase I, II evaluation
M Colozza, M Tonato, V Belsanti, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
September 1, 1990
Ondansetron (GR38032) in the prophylaxis of acute and delayed cisplatin-induced emesis
F Roila, S Bracarda, M Tonato, et al.
European Journal of Clinical Pharmacology
|
January 1, 1990
Assessment of nausea
A Del Favero, F Roila, C Basurto, et al.
Cancer
|
March 16, 2000
Oral estramustine and cyclophosphamide in patients with metastatic hormone refractory prostate carcinoma: a phase II study
S Bracarda, M Tonato, P Rosi, et al.
Cancer Genetics and Cytogenetics
|
June 1, 1993
Expression of aphidicolin-induced fragile sites in lymphocytes of patients with breast cancer
C Ardisia, G Venti, M A Colozza, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1990
A pilot study of metoclopramide, dexamethasone, diphenhydramine and acupuncture in women treated with cisplatin
L Aglietti, F Roila, M Tonato, et al.
American Journal of Clinical Oncology
|
April 1, 1996
Radiotherapy without steroids in selected metastatic spinal cord compression patients. A phase II trial
E Maranzano, P Latini, S Beneventi, et al.
American Journal of Clinical Oncology
|
June 19, 2001
Gemcitabine in advanced pancreatic cancer: a phase II trial
L Crinò, A M Mosconi, C Calandri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 1, 1993
Induction chemotherapy plus high-dose radiotherapy versus radiotherapy alone in locally advanced unresectable non-small-cell lung cancer
L Crinò, P Latini, M Meacci, et al.
American Journal of Clinical Oncology
|
November 5, 1997
Long-term results in patients with advanced epithelial ovarian carcinoma treated with a combination of cisplatin, doxorubicin, and cyclophosphamide
M Colozza, A M Mosconi, S Gori, et al.
Page
of 12
Search research articles
Search
Showing results (61-70 of 120) with videos related to
Sort By:
Page
of 12
Cancer
|
September 15, 1988
5-Fluorouracil and isoprinosine in the treatment of advanced colorectal cancer. A limited phase I, II evaluation
M Colozza, M Tonato, V Belsanti, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))
|
September 1, 1990
Ondansetron (GR38032) in the prophylaxis of acute and delayed cisplatin-induced emesis
F Roila, S Bracarda, M Tonato, et al.
European Journal of Clinical Pharmacology
|
January 1, 1990
Assessment of nausea
A Del Favero, F Roila, C Basurto, et al.
Cancer
|
March 16, 2000
Oral estramustine and cyclophosphamide in patients with metastatic hormone refractory prostate carcinoma: a phase II study
S Bracarda, M Tonato, P Rosi, et al.
Cancer Genetics and Cytogenetics
|
June 1, 1993
Expression of aphidicolin-induced fragile sites in lymphocytes of patients with breast cancer
C Ardisia, G Venti, M A Colozza, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1990
A pilot study of metoclopramide, dexamethasone, diphenhydramine and acupuncture in women treated with cisplatin
L Aglietti, F Roila, M Tonato, et al.
American Journal of Clinical Oncology
|
April 1, 1996
Radiotherapy without steroids in selected metastatic spinal cord compression patients. A phase II trial
E Maranzano, P Latini, S Beneventi, et al.
American Journal of Clinical Oncology
|
June 19, 2001
Gemcitabine in advanced pancreatic cancer: a phase II trial
L Crinò, A M Mosconi, C Calandri, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 1, 1993
Induction chemotherapy plus high-dose radiotherapy versus radiotherapy alone in locally advanced unresectable non-small-cell lung cancer
L Crinò, P Latini, M Meacci, et al.
American Journal of Clinical Oncology
|
November 5, 1997
Long-term results in patients with advanced epithelial ovarian carcinoma treated with a combination of cisplatin, doxorubicin, and cyclophosphamide
M Colozza, A M Mosconi, S Gori, et al.
Page
of 12